InsidersTradesSigma
Explore the detailed record of transactions filed by Wilson Marc, Chief Financial Officer. Director active across 1 company, notably Crinetics Pharmaceuticals, Inc.. Cumulatively, 1 reports have been published. Activity tracked since 28 February 2022. The latest transaction was filed on 28 February 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Wilson Marc is the Chief Financial Officer of Crinetics Pharmaceuticals, Inc. He is responsible for the financial management of the company, including budgeting and financial reporting.